Update date
31 Jan 2014
Shareable Research Card
PMCB - PharmaCyte Biotech, Inc. Operating Margin
This metric view shows PMCB - PharmaCyte Biotech, Inc. operating margin history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2013
- Latest reported value
- 396584%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Jan 2014
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q4 2013.
- Latest reported value on this page: 396584%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Operating Margin
Latest reported operating margin: 396584%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q4 2013
Ownership context was refreshed from SEC Forms 3/4/5 filed on 18 Mar 2026.
Benchmark Context
How Operating Margin compares with peers
PharmaCyte Biotech, Inc. sits in the top quarter of the current operating margin sample.
Compared with
Compared with 120 companies reporting operating margin in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 1817.4x the current sample midpoint. Operating Margin does not yet have enough prior-period data for a historical comparison on this page.
- Visible rows currently span reported period ends from 31 Dec 2010 to 31 Mar 2026.
- Nearby companies in this sample: NAMI Corp. and ALR Technologies SG Ltd..
- Current sample position: rank #4 of 120 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
PharmaCyte Biotech, Inc.: Operating Margin
Latest period: Q4 2013. Period end: 31 Jan 2014. Units: %. Frequency: quarterly and annual.
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Metric Snapshot
- Latest value
- 396584%
- Coverage range
- 30 Apr 2012 - 31 Jan 2014
- Fact rows
- 10
What This Metric Tells You
- Shows the reported level of operating margin over 30 Apr 2012 - 31 Jan 2014.
- Use consecutive periods in the table to assess trend direction when YoY change is unavailable.
- Built from 10 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
PharmaCyte Biotech, Inc. appears at rank #4 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Global Warming Solutions, Inc. (gwso) | 99905400% | Quarter - 30 Sep 2022 | Open Global Warming Solutions, Inc. Operating Margin |
| 2 | Tecnoglass Inc. (tgls) | 4822092% | Quarter - 30 Jun 2025 | Open Tecnoglass Inc. Operating Margin |
| 3 | NAMI Corp. | 1080289% | Quarter - 31 Mar 2021 | Open NAMI Corp. Operating Margin |
| 4 | PharmaCyte Biotech, Inc. (pmcb) | 396584% | Quarter - 31 Jan 2014 | Open PharmaCyte Biotech, Inc. Operating Margin |
| 5 | ALR Technologies SG Ltd. (alrtf) | 180380% | Year - 31 Dec 2022 | Open ALR Technologies SG Ltd. Operating Margin |
| 6 | MUSTANG BIO, INC. (mbio) | 83624% | Quarter - 30 Sep 2019 | Open MUSTANG BIO, INC. Operating Margin |
Metric Details
- Metric
- Operating Margin (OperatingMargin)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 30 Apr 2012 - 31 Jan 2014
- Facts on this page
- 10
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
PharmaCyte Biotech, Inc. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2013 | 396584% | +405318% | 01 Nov 2013 | 31 Jan 2014 | |
| Q3 2013 | 351400% | +355866% | 01 Aug 2013 | 31 Oct 2013 | |
| Q2 2013 | -46011% | -42576% | -1239% | 01 May 2013 | 31 Jul 2013 |
| Q1 2013 | -13852% | -10923% | -373% | 01 Feb 2013 | 30 Apr 2013 |
| Q4 2012 | -8734% | 01 Nov 2012 | 31 Jan 2013 | ||
| Q3 2012 | -4466% | 01 Aug 2012 | 31 Oct 2012 | ||
| Q2 2012 | -3436% | 01 May 2012 | 31 Jul 2012 | ||
| Q1 2012 | -2929% | 01 Feb 2012 | 30 Apr 2012 |
PharmaCyte Biotech, Inc. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2012 | -13852% | -10923% | -373% | 01 May 2012 | 30 Apr 2013 |
| 2011 | -2929% | 01 May 2011 | 30 Apr 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.